×
Stock Screener
Stock Research
Top Dividend Stocks
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Silexion Therapeutics Corp Financial Ratios for Analysis 2020-2025 | SLXN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Income Statement
Balance Sheet
Cash Flow Statement
Key Financial Ratios
Format: Annual
Format: Quarterly
Format: Annual
View Annual Reports
Loading...
Annual Data
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Current Ratio
0.0459
0.0811
1.1699
0.4322
Long-term Debt / Capital
-
-
-
-
Debt/Equity Ratio
-
-
-
-
Gross Margin
-
-
-
-
Operating Margin
-
-
-
-
EBIT Margin
-
-
-
-
EBITDA Margin
-
-
-
-
Pre-Tax Profit Margin
-
-
-
-
Net Profit Margin
-
-
-
-
Asset Turnover
-
-
-
-
Inventory Turnover Ratio
-
-
-
-
Receiveable Turnover
-
-
-
-
Days Sales In Receivables
-
-
-
-
ROE - Return On Equity
-9.2355
-48.557
797.0805
115.2185
Return On Tangible Equity
-9.2355
-48.5571
797.0685
115.2185
ROA - Return On Assets
4.5091
0.5
-0.6544
-151.3601
ROI - Return On Investment
-9.2355
-48.557
797.0807
115.2185
Book Value Per Share
-7.6421
-3.2268
-0.2542
-0.5143
Operating Cash Flow Per Share
-1.3684
6.0264
-3.2936
-0.5424
Free Cash Flow Per Share
-1.3684
6.0264
-3.2936
-0.5424
